The use of pulse wave velocity in predicting pre-eclampsia in high-risk women Por [email protected] The use of pulse wave velocity in predicting pre-eclampsia in high-risk women Read More »
Ambulatory blood pressure phenotypes and isolated elevation of office central or brachial blood pressure Por [email protected] Ambulatory blood pressure phenotypes and isolated elevation of office central or brachial blood pressure Read More »
Scalp Cooling in Preventing Persistent Chemotherapy-Induced Alopecia: A Randomized Controlled Trial Por [email protected] Scalp Cooling in Preventing Persistent Chemotherapy-Induced Alopecia: A Randomized Controlled Trial Read More »
Dose/Exposure Relationship of Exercise and Distant Recurrence in Primary Breast Cancer Por [email protected] Dose/Exposure Relationship of Exercise and Distant Recurrence in Primary Breast Cancer Read More »
Trastuzumab deruxtecan versus trastuzumab emtansine in HER2-positive metastatic breast cancer: long-term survival analysis of the DESTINY-Breast03 trial Por [email protected] Trastuzumab deruxtecan versus trastuzumab emtansine in HER2-positive metastatic breast cancer: long-term survival analysis of the DESTINY-Breast03 trial Read More »
The Role of Axillary Lymph Node Dissection versus Sentinel Lymph Node Dissection in Breast Cancer Patients with Clinical N2b–N3c Disease Who Receive Adjuvant Radiotherapy Por [email protected] The Role of Axillary Lymph Node Dissection versus Sentinel Lymph Node Dissection in Breast Cancer Patients with Clinical N2b–N3c Disease Who Receive Adjuvant Radiotherapy Read More »
Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancer Por [email protected] Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancer Read More »
Impact of Neoadjuvant Chemoimmunotherapy on Surgical Outcomes and Time to Radiation in Triple‑Negative Breast Cancer Por [email protected] Impact of Neoadjuvant Chemoimmunotherapy on Surgical Outcomes and Time to Radiation in Triple‑Negative Breast Cancer Read More »
Final results of RIGHT Choice: Ribociclib plus endocrine therapy vs combination chemotherapy in premenopausal women with clinically aggressive HR+/HER2− advanced breast cancer Por Adson Machado Final results of RIGHT Choice: Ribociclib plus endocrine therapy vs combination chemotherapy in premenopausal women with clinically aggressive HR+/HER2− advanced breast cancer Read More »
Effectiveness of gonadotropin‑releasing hormone agonists for ovarianfunction suppression in premenopausal patients with hormonereceptor‑positive breast cancer: a retrospective single‑centerreal‑world study Por Adson Machado Effectiveness of gonadotropin‑releasing hormone agonists for ovarianfunction suppression in premenopausal patients with hormonereceptor‑positive breast cancer: a retrospective single‑centerreal‑world study Read More »
Abemaciclib plus a nonsteroidal aromatase inhibitor as initial therapy for HR+, HER2- advanced breast cancer: Final overall survival results of MONARCH 3 Por [email protected] Abemaciclib plus a nonsteroidal aromatase inhibitor as initial therapy for HR+, HER2- advanced breast cancer: Final overall survival results of MONARCH 3 Read More »
Survival After Contralateral Axillary Metastasis in Breast Cancer Por [email protected] Survival After Contralateral Axillary Metastasis in Breast Cancer Read More »